Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages |
Contact Us
Start Over | Back to Previous Screen
Clonazepam Tablet
Status: Currently in Shortage
»Date first posted:
03/10/2023
»Therapeutic Categories: Neurology; Pediatric; Psychiatry
Accord Healthcare Inc. (Revised 11/18/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Tablet, .5 mg (NDC 16729-136-00) | Unavailable | 45-60 Days | Other |
| Tablet, .5 mg (NDC 16729-136-16) | Unavailable | 45-60 Days | Other |
| Tablet, 1 mg (NDC 16729-137-00) | Unavailable | 45-60 Days | Other |
| Tablet, 1 mg (NDC 16729-137-16) | Available | ||
| Tablet, 2 mg (NDC 16729-138-00) | Available | ||
| Tablet, 2 mg (NDC 16729-138-16) | Available |
Cheplapharm Arzneimittel GmbH (Reverified 11/15/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Klonopin, Tablet, .5 mg (NDC 61269-605-10) | Available | Marketed by H2-Pharma | |
| Klonopin, Tablet, 1 mg (NDC 61269-610-10) | Available | Marketed by H2-Pharma | |
| Klonopin, Tablet, 2 mg (NDC 61269-620-10) | Available | Marketed by H2-Pharma |
Prinston Pharmaceutical, Inc. (Reverified 11/01/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Clonazepam, Tablet, .5 mg (NDC 43547-406-10) | Available | Marketed by Solco Healthcare | |
| Clonazepam, Tablet, .5 mg (NDC 43547-406-11) | Available | Marketed by Solco Healthcare | |
| Clonazepam, Tablet, .5 mg (NDC 43547-406-50) | Available | Marketed by Solco Healthcare | |
| Clonazepam, Tablet, 1 mg (NDC 43547-407-10) | Available | Marketed by Solco Healthcare | |
| Clonazepam, Tablet, 1 mg (NDC 43547-407-11) | Available | Marketed by Solco Healthcare | |
| Clonazepam, Tablet, 1 mg (NDC 43547-407-50) | Available | Marketed by Solco Healthcare | |
| Clonazepam, Tablet, 2 mg (NDC 43547-408-10) | Available | Marketed by Solco Healthcare | |
| Clonazepam, Tablet, 2 mg (NDC 43547-408-50) | Available | Marketed by Solco Healthcare |
Rubicon Research Private Limited (Reverified 06/18/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Clonazepam, Tablet, .5 mg (NDC 72888-152-30) | Available | Marketed by Advagen Pharma Ltd. | |
| Clonazepam, Tablet, .5 mg (NDC 72888-152-01) | Available | Marketed by Advagen Pharma Ltd. | |
| Clonazepam, Tablet, .5 mg (NDC 72888-152-05) | Available | Marketed by Advagen Pharma Ltd. | |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-30) | Available | Marketed by Advagen Pharma Ltd. | |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-01) | Available | Marketed by Advagen Pharma Ltd. | |
| Clonazepam, Tablet, 1 mg (NDC 72888-153-05) | Available | Marketed by Advagen Pharma Ltd. | |
| Clonazepam, Tablet, 2 mg (NDC 72888-154-30) | Available | Marketed by Advagen Pharma Ltd. | |
| Clonazepam, Tablet, 2 mg (NDC 72888-154-01) | Available | Marketed by Advagen Pharma Ltd. | |
| Clonazepam, Tablet, 2 mg (NDC 72888-154-05) | Available | Marketed by Advagen Pharma Ltd. |
Teva Pharmaceuticals USA, Inc. (Revised 11/26/2024)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Clonazepam Tablets, USP CIV, Tablet, .5 mg (NDC 0093-0832-01) | Limited Availability | Estimated recovery April 2025 | Demand increase for the drug |
| Clonazepam Tablets, USP CIV, Tablet, .5 mg (NDC 0093-0832-05) | Available | ||
| Clonazepam Tablets, USP CIV, Tablet, 1 mg (NDC 0093-3212-01) | Available | ||
| Clonazepam Tablets, USP CIV, Tablet, 1 mg (NDC 0093-3212-05) | Available | ||
| Clonazepam Tablets, USP CIV, Tablet, 2 mg (NDC 0093-3213-01) | Limited Availability | Estimated recovery April 2025 | Demand increase for the drug |
| Clonazepam Tablets, USP CIV, Tablet, 2 mg (NDC 0093-3213-05) | Available |